search
Back to results

Clinical Performance and Safety of Suture-TOOL

Primary Purpose

Laparotomy, Incisional Hernia, Wound Infection

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Suture-TOOL
Sponsored by
Suturion AB
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Laparotomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Informed consent: signed written informed consent before inclusion in the investigation Sex, age: male and female patients, ≥ 18 years old Surgery: elective open abdominal surgery for benign or malignant colorectal disease through midline incision. Anticipated incision length ≥ 12 cm Body Mass Index (BMI): 18 - 40 kg/m2 inclusive Full comprehension: ability to comprehend the full nature and purpose of the investigation, including possible risks and side effects; ability to co-operate with the Investigator and to comply with the requirements of the entire investigation. Exclusion Criteria: Abdominal Surgery: previous abdominal surgery involving the midline Physical findings: clinically significant abnormal physical findings which could interfere with the objectives of the investigation according to the Investigator's opinion; existing midline hernia, cutaneous infection, fistula, psoriasis of abdominal skin; morbidly obese patients Pre-operative findings: any pre-operative findings identified by the surgeon/Investigator that may preclude the conduct of the investigation procedures Allergy: history of anaphylaxis to drugs or allergic reactions in general, which the Investigator considers could affect the outcome of the investigation Diseases: known or identified at surgery disseminated cancer disease; collagen diseases and immune deficiency disorders, according to the Investigator's opinion. Significant history of renal, hepatic, gastrointestinal, cardiovascular, respiratory, skin, haematological, endocrine or neurological diseases that according to the Investigator's opinion may interfere with the aim of the investigation Life expectancy: life expectancy less than 1 year Medications: any medication that could interfere with the investigation procedures or investigation outcome, according to the Investigator's opinion. Hormonal contraceptives for women are allowed Pregnancy and lactation: positive pregnancy test at screening (if applicable); pregnant or breastfeeding women Vulnerable subjects: Individuals unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response (ISO 14155:2020 §3.55) will be excluded

Sites / Locations

  • Helsingborgs HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Single arm

Arm Description

Closure of the abdomen after laparotomy with Suture-TOOL.

Outcomes

Primary Outcome Measures

Proportion of patients with Suture length/Wound length (SL/WL) ratio ≥ 4
SL/WL-ratio of patients laparotomy closures will be calculated by measuring (centimeter) and dividing the length of used suture with the length of the laparotomy wound.

Secondary Outcome Measures

Stitch count
Number of stitches used for laparotomy closure
Numbers of sutures used
Incision closure time
Time (seconds) from first to last knot during laparotomy closure
Surgeons´ comfort with device during closure
VAS assessment
Surgeons´ satisfaction with final closure result
VAS assessment

Full Information

First Posted
January 9, 2023
Last Updated
January 14, 2023
Sponsor
Suturion AB
Collaborators
Helsingborgs Hospital, Cross Research S.A.
search

1. Study Identification

Unique Protocol Identification Number
NCT05695157
Brief Title
Clinical Performance and Safety of Suture-TOOL
Official Title
Clinical Performance and Safety of Suture-TOOL for Abdominal Wound Closure in Men and Women Patients Undergoing Elective Open Abdominal Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 10, 2023 (Actual)
Primary Completion Date
August 30, 2023 (Anticipated)
Study Completion Date
August 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Suturion AB
Collaborators
Helsingborgs Hospital, Cross Research S.A.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this single arm intervention study is to investigate the safety and performance of a suturing device for closure of the midline incision after open abdominal surgery. The study population consists of 38 patients selected for open abdominal procedures for malignant and benign colorectal disease. The main question it aims to answer is: • If the device facilitates a Suture-Length to Wound-Length (SL/WL) ratio of 4:1 Participants laparotomy wound will be closed with the device at the end of the operation and closure related data as closure time and SL/WL ratio will be calculated. The wound will be assessed for infection during the postoperative stay and the chart will be reviewed for wound dehiscence and wound infection.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Laparotomy, Incisional Hernia, Wound Infection, Closure Technique

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Single arm prospective interventional study
Masking
None (Open Label)
Allocation
N/A
Enrollment
38 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Single arm
Arm Type
Experimental
Arm Description
Closure of the abdomen after laparotomy with Suture-TOOL.
Intervention Type
Device
Intervention Name(s)
Suture-TOOL
Intervention Description
Suture device for fast and standardized closure of the abdominal fascia
Primary Outcome Measure Information:
Title
Proportion of patients with Suture length/Wound length (SL/WL) ratio ≥ 4
Description
SL/WL-ratio of patients laparotomy closures will be calculated by measuring (centimeter) and dividing the length of used suture with the length of the laparotomy wound.
Time Frame
Measured during laparotomy closure.
Secondary Outcome Measure Information:
Title
Stitch count
Description
Number of stitches used for laparotomy closure
Time Frame
Measured during laparotomy closure
Title
Numbers of sutures used
Time Frame
Counted during laparotomy closure
Title
Incision closure time
Description
Time (seconds) from first to last knot during laparotomy closure
Time Frame
Measured during laparotomy closure
Title
Surgeons´ comfort with device during closure
Description
VAS assessment
Time Frame
After laparotomy closure
Title
Surgeons´ satisfaction with final closure result
Description
VAS assessment
Time Frame
After laparotomy closure
Other Pre-specified Outcome Measures:
Title
Incision not following the midline (exposure of rectus muscle)
Description
Assessment of midline incision
Time Frame
During the whole study period of up to 8 months
Title
Thickness of subcutaneous fat
Description
Measurement of subcutaneous fat (millimeter)
Time Frame
During the whole study period of up to 8 months
Title
Glove punctures
Description
Standardized assessment of puncture holes
Time Frame
During the whole study period of up to 8 months
Title
Re-operation(s) number
Description
Chart review
Time Frame
45 days after surgery
Title
Reasons for unscheduled post-surgery visits
Description
Chart review
Time Frame
45 days after surgery
Title
Type of adverse effects
Description
All adverse effects derived by spontaneous, unsolicited reports of the subjects or users/handlers, by observation and by routine open questioning will be collected and reported.
Time Frame
During the whole study period of up to 8 months
Title
Type of adverse device effects
Description
Identification of adverse device effects
Time Frame
During the whole study period of up to 8 months
Title
Type of device deficiencies
Description
Identification of device deficiences
Time Frame
During the whole study period of up to 8 months
Title
Reasons for device replacement during surgery
Description
Identification during study period
Time Frame
During the whole study period of up to 8 months
Title
Patients with wound infections
Description
Wound infection postoperatively
Time Frame
45 days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Informed consent: signed written informed consent before inclusion in the investigation Sex, age: male and female patients, ≥ 18 years old Surgery: elective open abdominal surgery for benign or malignant colorectal disease through midline incision. Anticipated incision length ≥ 12 cm Body Mass Index (BMI): 18 - 40 kg/m2 inclusive Full comprehension: ability to comprehend the full nature and purpose of the investigation, including possible risks and side effects; ability to co-operate with the Investigator and to comply with the requirements of the entire investigation. Exclusion Criteria: Abdominal Surgery: previous abdominal surgery involving the midline Physical findings: clinically significant abnormal physical findings which could interfere with the objectives of the investigation according to the Investigator's opinion; existing midline hernia, cutaneous infection, fistula, psoriasis of abdominal skin; morbidly obese patients Pre-operative findings: any pre-operative findings identified by the surgeon/Investigator that may preclude the conduct of the investigation procedures Allergy: history of anaphylaxis to drugs or allergic reactions in general, which the Investigator considers could affect the outcome of the investigation Diseases: known or identified at surgery disseminated cancer disease; collagen diseases and immune deficiency disorders, according to the Investigator's opinion. Significant history of renal, hepatic, gastrointestinal, cardiovascular, respiratory, skin, haematological, endocrine or neurological diseases that according to the Investigator's opinion may interfere with the aim of the investigation Life expectancy: life expectancy less than 1 year Medications: any medication that could interfere with the investigation procedures or investigation outcome, according to the Investigator's opinion. Hormonal contraceptives for women are allowed Pregnancy and lactation: positive pregnancy test at screening (if applicable); pregnant or breastfeeding women Vulnerable subjects: Individuals unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response (ISO 14155:2020 §3.55) will be excluded
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lena Toft, RN
Phone
+46(0)424061570
Email
lena.toft@skane.se
First Name & Middle Initial & Last Name or Official Title & Degree
Marcus Edelhamre, MD Phd
Phone
+46(0)424061555
Email
marcus.edelhamre@skane.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marcus Edelhamre, MD Phd
Organizational Affiliation
Region Skåne
Official's Role
Principal Investigator
Facility Information:
Facility Name
Helsingborgs Hospital
City
Helsingborg
State/Province
Scania
ZIP/Postal Code
25187
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marcus Edelhamre, MD Phd
Phone
+46(0)424061555
Email
marcus.edelhamre@skane.se
First Name & Middle Initial & Last Name & Degree
Gabriel Börner, MD
Phone
+46(0)424061276
Email
gabriel.borner@med.lu.se

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31549201
Citation
Borner G, Montgomery A. Suture-Tool: A Mechanical Needle Driver for Standardized Wound Closure. World J Surg. 2020 Jan;44(1):95-99. doi: 10.1007/s00268-019-05179-5.
Results Reference
result
Citation
Borner G, Edelhamre M, Rogmark P, Montgomery A. Suture-TOOL: A suturing device for swift and standardized abdominal aponeurosis closure. Surgery in Practice and Science 2022 11. 100137/doi.org/10.1016
Results Reference
result

Learn more about this trial

Clinical Performance and Safety of Suture-TOOL

We'll reach out to this number within 24 hrs